{"id":152608,"name":"AMERICAN HOSPITAL ASSOCIATION","slug":"american-hospital-association","state":"DC","description":null,"totalSpending":1300000,"filings":26,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":200000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":150000},{"year":2024,"income":150000},{"year":2025,"income":200000}],"firms":["O'NEILL, ATHY & CASEY, P.C."],"lobbyists":["CHRISTOPHER O'NEILL"],"issues":["TAX","LBR","HCR","MMM","BUD"],"sampleDescriptions":["H.R. 5003, Restore tax exemption for advanced refunding bonds","H.R. 659, \"Standard Merger and Acquisition Reviews Through Equal Rules Act\" - provisions related to standardizing FTC and DOJ authority and procedures under the Clayton Act","Proposed changes to Medicare hospital reimbursement policy\nHealth care policy\nH.R. 1892, Bipartisan Budget Act of 2018 - provisions related to Medicare hospital payments and policy and funding to address opioid abuse. Monitored discussions related to potential reductions to Medicare payments.\nH.R. 1625, Consolidated Appropriations Act of 2018 - provisions related to health program funding. \nH.R. 5311/S. 2456, CARA 2.0 - provisions related to federal support and opioid prescribing policy\nLegislative proposals to combat opioid abuse","Proposed changes to Medicare hospital reimbursement policy\nIssues related to the Hospital Compare Star Ratings\nS. 568/H.R.1421, \"Improving Access to Medicare Coverage Act\" - provisions related to counting outpatient observation services toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare\nH.R. 2267/S. 1301, \"Resident Physician Shortage Reduction Act\" - provisions related to increasing the number of Medicare-funded residency positions\nH.R. 4392, a bill to prevent cuts to the 340B drug savings program, which would provide relief from deep cuts to payments to hospitals participating in the 340B program\nOpposed H.R. 4710, a bill to implement reporting requirement for certain 340B participants and to establish a 2-year moratorium on new 340B program participants","House and Senate FY 2018 Labor, HHS, Education appropriations - provisions related to funding health programs\nH.R. 1892, Bipartisan Budget Act of 2018 - provisions related to Medicare hospital payments and policy and funding to address opioid abuse. Monitored discussions related to potential reductions to Medicare payments.\nH.R. 1625, Consolidated Appropriations Act of 2018 - provisions related to health program funding.","H.R. 5645, \"Standard Merger and Acquisition Reviews Through Equal Rules Act\" - provisions related to standardizing FTC and DOJ authority and procedures under the Clayton Act\nS. 2847, Standard Merger and Acquisition Reviews Through Equal Rules Act - provisions related to standardizing FTC and DOJ authority and procedures under the Clayton Act","House and Senate FY 2019 Labor, HHS, Education appropriations - provisions related to funding health programs","Proposed changes to Medicare hospital reimbursement policy\nHealth care policy\nS. 2680, Opioid Crisis Response Act\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act - provisions related to IMD exclusion and alignment of 42 CFR Part 2 regulations with HIPPA\nH.R. 5797, Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act\nH.R. 6082, Overdose Prevention and Patient Safety Act\nHelping to End Addiction and Lessen (HEAL) Substance Use Disorders Act\nH.R. 5311/S. 2456, CARA 2.0 - provisions related to federal support and opioid prescribing policy\nLegislative proposals to combat opioid abuse\nS. 2597/H.R. 5385, Children's Hospital GME Support Reauthorization Act of 2018 \nH.R. 959/S. 1109, Title VIII Nursing Workforce Reauthorization Act \nSupport S.781/ HR 1876, Good Samaritan Health Professional Act of 2017 - provisions related to limiting the liability of health care professionals who volunteer to provide health care services in response to a disaster","Proposed changes to Medicare hospital reimbursement policy\nIssues related to the Hospital Compare Star Ratings\nS. 568/H.R.1421, \"Improving Access to Medicare Coverage Act\" - provisions related to counting outpatient observation services toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare\nH.R. 2267/S. 1301, \"Resident Physician Shortage Reduction Act\" - provisions related to increasing the number of Medicare-funded residency positions\nH.R. 4392, a bill to prevent cuts to the 340B drug savings program, which would provide relief from deep cuts to payments to hospitals participating in the 340B program\nOpposed H.R. 4710, a bill to implement reporting requirement for certain 340B participants and to establish a 2-year moratorium on new 340B program participants \nH.R. 6071, Stretching Entity Resources for Vulnerable Communities Act - provisions related to rescinding Medicare reimbursements cuts, codify the definition of patient\nAdditional legislative proposals modifying the 340B program\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act - provisions related to Medicare and Medicaid policy and reimbursement","H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019","Proposed changes to Medicare hospital reimbursement policy\nHealth care policy\nS. 2680, Opioid Crisis Response Act\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act - provisions related to IMD exclusion, alignment of 42 CFR Part 2 regulations with HIPAA, opioid-alternative prescribing, and medication-assisted treatment provisions\nHelping to End Addiction and Lessen (HEAL) Substance Use Disorders Act\nLegislative proposals to combat opioid abuse\nS. 2597/H.R. 5385, Children's Hospital GME Support Reauthorization Act of 2018 \nH.R. 959/S. 1109, Title VIII Nursing Workforce Reauthorization Act \nSupport S.781/ HR 1876, Good Samaritan Health Professional Act of 2017 - provisions related to limiting the liability of health care professionals who volunteer to provide health care services in response to a disaster","Proposed changes to Medicare hospital reimbursement policy\nHealth care policy\nH.R. 959/S. 1109, Title VIII Nursing Workforce Reauthorization Act \nSupport S.781/H.R. 1876, Good Samaritan Health Professional Act of 2017 - provisions related to limiting the liability of health care professionals who volunteer to provide health care services in response to a disaster \n42 CFR Part 2 alignment with HIPAA\nS. 2852/H.R. 6378, Pandemic and All-Hazards Preparedness & Advancing Innovation Act - provisions related to hospitals","Proposed changes to Medicare hospital reimbursement policy\nIssues related to the Hospital Compare Star Ratings\nS. 568/H.R.1421, \"Improving Access to Medicare Coverage Act\" - provisions related to counting outpatient observation services toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare\nH.R. 2267/S. 1301, \"Resident Physician Shortage Reduction Act\" - provisions related to increasing the number of Medicare-funded residency positions\nH.R. 4392, a bill to prevent cuts to the 340B drug savings program, which would provide relief from deep cuts to payments to hospitals participating in the 340B program\nOpposed H.R. 4710, a bill to implement reporting requirement for certain 340B participants and to establish a 2-year moratorium on new 340B program participants \nH.R. 6071, Stretching Entity Resources for Vulnerable Communities Act - provisions related to rescinding Medicare reimbursements cuts, codify the definition of patient\nAdditional legislative proposals modifying the 340B program","Proposed changes to Medicare hospital reimbursement policy\nHealth care policy\nH.R. 728, \"Title VIII Nursing Workforce Reauthorization Act\"\n42 CFR Part 2 alignment with HIPAA\nH.R. 269, \"Pandemic and All-Hazards Preparedness& Advancing Innovation Act\" - provisions related to hospitals\nH.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act\" - provisions related to studying rising hospital drug prices and reporting of drug costs\nAdditional legislative proposals to address rising drug costs\nH.R. 1559, \"340B Protection and Accountability Act\"\nAdditional legislative proposals modifying the 340B program\nSurprise billing","Proposed changes to Medicare hospital reimbursement policy\nIssues related to the Hospital Compare Star Ratings\nH.R. 1682/S. 753, \"Improving Access to Medicare Coverage Act\" - provisions related to counting outpatient observation services toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare\nH.R. 1763/S. 348, \"Resident Physician Shortage Reduction Act\" - provisions related to increasing the number of Medicare-funded residency positions\nSite-neutral payment policies\nMedicare for All and the Public Option alternatives","Proposals to raise budget caps\nHouse and Senate FY 2020 Labor, HHS, Education appropriations - provisions related to funding for health programs","Proposals to raise budget caps\nH.R. 2740 and Senate FY 2020 Labor, HHS, Education appropriations - provisions related to funding for health programs","Proposed changes to Medicare hospital reimbursement policy\nHealth care policy\nH.R. 728, \"Title VIII Nursing Workforce Reauthorization Act\"\n42 CFR Part 2 alignment with HIPAA\nH.R. 269/S. 1379, \"Pandemic and All-Hazards Preparedness& Advancing Innovation Act\" - provisions related to hospitals\nH.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act\" - provisions related to studying rising hospital drug prices and reporting of drug costs\nH.R. 965/S. 340, \"CREATES Act\"\nAdditional legislative proposals to address rising drug costs\nH.R. 1559, \"340B Protection and Accountability Act\"\nAdditional legislative proposals modifying the 340B program\nS.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements\nS. 1531, \"STOP Surprise Medical Bills Act\"\nHouse legislation - \"No Surprises Act\"\nH.R. 3502, \"Protecting People from Surprise Medical Bills Act\"\nOther proposals to address surprise billing\nProposals to strengthen the health care system and achieve ACA market stability","Proposed changes to Medicare hospital reimbursement policy\nIssues related to the Hospital Compare Star Ratings\nH.R. 1682/S. 753, \"Improving Access to Medicare Coverage Act\" - provisions related to counting outpatient observation services toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare\nH.R. 1763/S. 348, \"Resident Physician Shortage Reduction Act\" - provisions related to increasing the number of Medicare-funded residency positions\nSite-neutral payment policies\nH.R. 1384/S. 1129, Medicare for All and the Public Option alternatives","Proposed changes to Medicare hospital reimbursement policy\nHealth care policy\n42 CFR Part 2 alignment with HIPAA\nH.R. 986/S. 466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the ACA shall have no force or effect\nH.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act\" - provisions related to studying rising hospital drug prices and reporting of drug costs\nH.R. 965/S. 340, \"CREATES Act\"\nH.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 - provisions related to eligibility for approval of a subsequent generic drug and to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval\nH.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019 - provisions related to prohibiting brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products\nAdditional legislative proposals to address rising drug costs\nH.R. 1559, \"340B Protection and Accountability Act\"\nAdditional legislative proposals modifying the 340B program\nS.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements\nS. 1531, \"STOP Surprise Medical Bills Act\"\nH.R. 3630, \"No Surprises Act\"\nOther proposals to address surprise billing\nProposals to strengthen the health care system and achieve ACA market stability"],"years":[2018,2019,2020,2021,2022,2024,2025]}